Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-057336

Director sold 10,000 shares at $50.18 ($501,830)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Director 2020-11-04 Sale −10,000 $50.18 $501,830 65,000 D
Open-market sales · 10,000 sh · avg $50.18 · $501,830
Loading xslF345X03/doc4.xml…